前列腺MRI在局限性前列腺癌立体定向体部放疗计划制定与实施中的应用
本文综述前列腺MRI在局限性前列腺癌立体定向体部放疗(SBRT)计划制定与实施中的应用。SBRT已被美国国家综合癌症网络(NCCN)认可为低、中、高危前列腺癌可接受的根治性治疗方案。文章讨论MRI用于识别膜部及前列腺部尿道以降低剂量、识别前列腺尖部及包膜外侵犯或精囊侵犯区域、验证优势前列腺内病灶的剂量提升,以及评估基准标记物和水凝胶间隔物放置。
要点
- MRI识别膜部及前列腺部尿道有助于在SBRT中降低其剂量,从而可能减少急性和晚期毒性。
- MRI有助于识别前列腺尖部及包膜外侵犯或精囊侵犯区域,以实现适当剂量覆盖。
- 前列腺MRI正被用于验证优势前列腺内病灶的识别和剂量提升,可能改善肿瘤学结局。
核心结论
- 前列腺MRI在SBRT计划制定与实施中具有多种用途,包括识别并降低膜部及前列腺部尿道剂量、识别前列腺尖部及包膜外侵犯或精囊侵犯区域以实现适当剂量覆盖、验证优势前列腺内病灶的剂量提升,以及评估基准标记物和水凝胶间隔物的放置。
研究设计与样本
- 综述性文章,纳入内容涉及前瞻性研究中对前列腺MRI用于识别优势前列腺内病灶并进行剂量提升的验证;未报告具体检索范围、纳入文献数量、样本量或中心数。
诊断标准与关键数值
- 原文未报告敏感度、特异度、AUC、阈值或分级标准。
- SBRT通常以五次或更少分次向颅外靶区给予高剂量辐射。
- NCCN将SBRT认可为低、中、高危前列腺癌可接受的根治性治疗方案。
临床应用与阅片要点
- 阅片时可关注膜部及前列腺部尿道的识别,以协助SBRT中降低该区域剂量,可能减少急性和晚期毒性。
- 阅片时注意前列腺尖部及包膜外侵犯或精囊侵犯区域,以协助实现适当剂量覆盖。
- 在前瞻性研究中,前列腺MRI正被验证用于识别优势前列腺内病灶并进行剂量提升,可能改善肿瘤学结局。
- 可用于评估基准标记物和水凝胶间隔物在放疗计划与实施中的放置。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Prostate MRI is increasingly being used to make diagnoses and guide management for patients receiving definitive radiation treatment for prostate cancer. Radiologists should be familiar with the potential uses of prostate MRI in radiation therapy planning and delivery. Radiation therapy is an established option for the definitive treatment of localized prostate cancer. Stereotactic body radiation therapy (SBRT) is an external-beam radiation therapy method used to deliver a high dose of radiation to an extracranial target in the body, often in five or fewer fractions. SBRT is increasingly being used for prostate cancer treatment and has been recognized by the National Comprehensive Cancer Network as an acceptable definitive treatment regimen for low-, intermediate-, and high-risk prostate cancer. MRI is commonly used to aid in prostate radiation therapy. The authors review the uses of prostate MRI in SBRT treatment planning and delivery. Specific topics discussed include the use of prostate MRI for identification of and dose reduction to the membranous and prostatic urethra, which can decrease the risk of acute and late toxicities. MRI is also useful for identification and appropriate dose coverage of the prostate apex and areas of extraprostatic extension or seminal vesicle invasion. In prospective studies, prostate MRI is being validated for identification of and dose intensification to dominant intraprostatic lesions, which potentially can improve oncologic outcomes. It also can be used to evaluate the placement of fiducial markers and hydrogel spacers for radiation therapy planning and delivery. ©RSNA, 2022.
引用
- Nigogosyan, Ippolito, Collins, et al. Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer. Radiographics. 2022. PMID: 35714039. doi:10.1148/rg.210114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。